DLG4 and Cognitive impairment: More importantly, we found for the first time that dexmedetomidine pre- and posttreatment both effectively ameliorated hypoxia-induced cognitive impairment and hippocampal synaptic loss, as evidenced by significant increases in PSD95 expression, synapse numbers, and PSD thickness during early and advanced stages of postnatal development.